Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003461502 | SCV004199182 | likely pathogenic | Fanconi anemia complementation group G | 2023-11-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003636028 | SCV004508192 | pathogenic | Fanconi anemia | 2023-08-22 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individual(s) with FANCG-related conditions (PMID: 26689913). This variant is present in population databases (rs778986343, gnomAD 0.007%). This sequence change creates a premature translational stop signal (p.Tyr447*) in the FANCG gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FANCG are known to be pathogenic (PMID: 12552564). |